FG-4592 in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa

Condition:   Anemia in Chronic Kidney Disease in Non-dialysis PatientsInterventions:   Drug: FG-4592;   Drug: darbepoetin alfaSponsors:   Astellas Pharma Europe B.V.;   FibroGenRecruiting - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials